You searched for Type 1 diabetes

News and Trends 30 May 2023

Researchers identify gene expression signature to predict progression of type 1 diabetes

Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression signature that can predict the progression of type 1 diabetes.The…

May 30, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 27 Jan 2023

Psoriasis drug may help treat type 1 diabetes

A large clinical study is now beginning on an approved drug for treating psoriasis. The drug will be tested on patients who were recently diagnosed with type 1 diabetes. The…

January 27, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 10 Nov 2022

Promising drug candidate discovered for prevention of type 1 diabetes

According to a new study in Finland, type 1 diabetes could be prevented by inhibiting a gene associated with the onset of the disease. A drug based on the same…

November 10, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Sep 2022

Adocia takes steps with implants for treatment of type 1 diabetes

French biopharma company Adocia has established a first proof of concept for its AdoShell Islets implant by achieving glycemic control without insulin injections in immunocompetent diabetic rats during a 132-day…

September 7, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 2 Aug 2022

COUR NanoParticle technology halts Type 1 diabetes progression

COUR Pharmaceuticals has published details of a study with the Miller Lab at Northwestern University, looking at type 1 diabetes. COUR develops novel immune-modifying nanoparticles (COUR NanoParticles or CNPs) designed…

August 2, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Jun 2022

Type 1 diabetes in the crosshairs with Imagine Pharma discovery

U.S. biotech company Imagine Pharma is showcasing its discovery of Type 1 Diabetes Activated Islet Progenitor Cells (T1D AIPCs) at the American Transplant Congress in Boston. The company said its…

June 6, 2022 - 2 minutesmins - By Jim Cornall

In Depth 3 Mar 2020

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their condition that still leave them at risk of long-term complications. Immunotherapy could one day become…

March 3, 2020 - 8 minutesmins - By Clara Rodríguez Fernández

diabeloop artificial pancreas type 1 diabetes

News and Trends 2 Dec 2019

€31M Series B Funds Rollout of Artificial Pancreas in Type 1 Diabetes

The French biotech Diabeloop has raised €31M to launch an artificial pancreas device designed to automatically control the blood glucose levels of type 1 diabetes patients. According to Diabeloop, this…

December 2, 2019 - 3 minutesmins - By Jonathan Smith

imcyse type 1 diabetes insulin immunotherapy

News and Trends 28 Aug 2019

Type 1 Diabetes Immunotherapy Shows Promise in Phase I

An immunotherapy designed by the Belgian biotech Imcyse to prevent type 1 diabetes has shown signs of clinical benefits and no major safety issues in a phase I trial. The…

August 28, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 18 Jun 2019

Belgian Biotech’s €35M Series B to Fund Potential Type 1 Diabetes Cure

The Belgian company Imcyse has raised €35M in a Series B round to develop a potential cure for chronic autoimmune conditions including type 1 diabetes and multiple sclerosis. Imcyse will…

June 18, 2019 - 2 minutesmins - By Jonathan Smith

artificial pancreas blood sugar type 1 diabetes

News and Trends 3 Oct 2018

Algorithm Proves Better Than Humans at Controlling Blood Sugar in Type 1 Diabetes

A clinical trial has shown that letting an algorithm decide the amount of insulin a person with type 1 diabetes needs can help keep blood sugar levels under control. The…

October 3, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Cheese Producing Bacteria Could Help Treat Type 1 Diabetes

News and Trends 3 Apr 2018

Cheese-Producing Bacteria Could Help Reverse Type 1 Diabetes

ActoBio Therapeutics has received permission from the FDA to start a clinical trial for a type 1 diabetes treatment that uses a bacterial strain also used in cheese production. After…

April 3, 2018 - 2 minutesmins - By Editorial Team

News and Trends 7 Dec 2017

French Biotech’s Type 1 Diabetes Candidate Ready to Battle it Out with Big Pharma

Adocia’s rapid-action insulin outperforms Novo Nordisk’s market approved treatment for type 1 diabetes during a Phase I study. Adocia specializes in new formulations of therapeutic proteins, particularly for the treatment…

December 7, 2017 - 3 minutesmins - By Alex Dale

imcyse type 1 diabetes immunotherapy cure

News and Trends 15 Nov 2017

Update: Belgian Biotech Starts Human Trials for a Potential Type 1 Diabetes Cure

Update (15/11/2017): Imcyse has officially started recruiting patients to test its therapy for type 1 diabetes. The clinical trial will recruit up to 40 patients across 15 European centers, and…

November 15, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 22 Jun 2023

FDA approves type 2 diabetes drug for children 10 and older

The U.S. Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) 10 mg and 25 mg tablets to lower blood sugar along with diet and exercise in children 10 years…

June 22, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 19 Oct 2022

CDF15 cytokine a promising therapeutic target against type 2 diabetes

CDF15 cytokine a promising therapeutic target against type 2 diabetes Researchers have conducted a review study on growth differentiation factor 15 (GDF15) — a protein expressed under physiological stress conditions…

October 19, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 26 Jul 2023

Diabetes drug could promote healthy aging

A research team from the School of Public Health, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has provided genetic evidence that metformin might promote healthy aging…

July 26, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 12 May 2023

DiogenX raises €27.5M for “breakthrough” diabetes treatment

DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, has announced the successful completion of a €27.5 million ($30 million) Series A financing round. …

May 12, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 13 Apr 2023

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

Aspect Biosystems and Novo Nordisk A/S are set to collaborate on developing bioprinted tissue therapeutics to replace, repair, or supplement biological functions inside the body with the aim of delivering…

April 13, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 15 Mar 2023

10 immunotherapy companies making waves in 2023

Immunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is regarded as the father of immunotherapy, first attempted to leverage the immune system for oncological…

March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering